Ramy Farid, Schrödinger CEO

An AI, err ma­chine learn­ing, shop lines up Eli Lil­ly as part­ner ahead of first in-house clin­i­cal tri­al

Life sci­ences soft­ware de­vel­op­er and drug dis­cov­ery out­fit Schrödinger, dur­ing its “plat­form day,” out­lined its pro­grams and path for­ward two months af­ter bring­ing on board long-time biotech an­a­lyst Ge­of­frey Porges, who told End­points News on his first day that the com­pa­ny’s sto­ry had been “over-sim­pli­fied.”

As part of telling its sto­ry on Thurs­day, which in­clud­ed slides of Schrödinger cats, the New York-based com­pa­ny dis­closed an­oth­er part­ner, adding to the dozen or so col­lab­o­ra­tions in the works at Schrödinger.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.